S
Sofwave Medical Ltd
TASE:SOFW
Sofwave Medical Ltd
TASE:SOFW
Price:
3 752
ILS
3.16%
Market Closed
Market Cap:
₪1.3B
Income Statement
Earnings Waterfall
Sofwave Medical Ltd
Sofwave Medical Ltd
Income Statement
Sofwave Medical Ltd
Sofwave Medical Ltd
Currency: USD
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
22
N/A
|
25
+16%
|
36
+41%
|
34
-4%
|
47
+36%
|
50
+8%
|
53
+6%
|
55
+4%
|
57
+2%
|
60
+5%
|
63
+6%
|
69
+10%
|
77
+11%
|
|
| Gross Profit | ||||||||||||||
| Cost of Revenue |
(6)
|
(7)
|
(9)
|
(9)
|
(12)
|
(13)
|
(13)
|
(14)
|
(14)
|
(14)
|
(15)
|
(17)
|
(19)
|
|
| Gross Profit |
16
N/A
|
19
+16%
|
26
+40%
|
26
-3%
|
34
+35%
|
37
+9%
|
40
+6%
|
42
+5%
|
43
+3%
|
45
+6%
|
48
+6%
|
53
+10%
|
58
+10%
|
|
| Operating Income | ||||||||||||||
| Operating Expenses |
(25)
|
(34)
|
(44)
|
(37)
|
(47)
|
(45)
|
(45)
|
(45)
|
(47)
|
(49)
|
(52)
|
(53)
|
(56)
|
|
| Selling, General & Administrative |
(17)
|
(23)
|
(31)
|
(27)
|
(34)
|
(33)
|
(34)
|
(35)
|
(36)
|
(37)
|
(41)
|
(42)
|
(44)
|
|
| Research & Development |
(8)
|
(11)
|
(12)
|
(10)
|
(12)
|
(11)
|
(11)
|
(11)
|
(11)
|
(10)
|
(11)
|
(11)
|
(12)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(9)
N/A
|
(16)
-76%
|
(17)
-11%
|
(11)
+36%
|
(12)
-11%
|
(8)
+35%
|
(5)
+35%
|
(4)
+32%
|
(4)
-3%
|
(4)
+2%
|
(4)
+0%
|
(0)
+95%
|
3
N/A
|
|
| Pre-Tax Income | ||||||||||||||
| Interest Income Expense |
2
|
(0)
|
(2)
|
(0)
|
(0)
|
1
|
(0)
|
(0)
|
(0)
|
1
|
(1)
|
(1)
|
(1)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(7)
N/A
|
(16)
-119%
|
(19)
-23%
|
(11)
+42%
|
(12)
-11%
|
(8)
+34%
|
(5)
+35%
|
(4)
+28%
|
(4)
-2%
|
(4)
-3%
|
(4)
-5%
|
(1)
+69%
|
1
N/A
|
|
| Net Income | ||||||||||||||
| Tax Provision |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
|
| Income from Continuing Operations |
(7)
|
(15)
|
(20)
|
(11)
|
(13)
|
(8)
|
(5)
|
(4)
|
(4)
|
(5)
|
(5)
|
(2)
|
1
|
|
| Net Income (Common) |
(7)
N/A
|
(15)
-125%
|
(20)
-27%
|
(11)
+41%
|
(13)
-11%
|
(8)
+35%
|
(5)
+34%
|
(4)
+24%
|
(4)
-2%
|
(5)
-8%
|
(5)
-3%
|
(2)
+65%
|
1
N/A
|
|
| EPS (Diluted) |
-0.2
N/A
|
-0.45
-125%
|
-0.57
-27%
|
-0.34
+40%
|
-0.37
-9%
|
-0.24
+35%
|
-0.16
+33%
|
-0.12
+25%
|
-0.12
N/A
|
-0.13
-8%
|
-0.14
-8%
|
-0.05
+64%
|
0.01
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
